Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.35B |
| 2 |
Amazon
AMZN
|
+$1.2B |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$1B |
| 4 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$561M |
| 5 |
Tencent Music
TME
|
+$553M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.54B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$996M |
| 3 |
Alibaba
BABA
|
+$587M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$586M |
| 5 |
Apple
AAPL
|
+$455M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 2.84% |
| 2 | Communication Services | 2.06% |
| 3 | Technology | 2% |
| 4 | Healthcare | 1.06% |
| 5 | Financials | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7376
NextTrip
NTRP
$22.7M
| $357K | ﹤0.01% |
+4,802
| New | +$392K |
|
7377
Coherus Oncology
CHRS
$192M
| $356K | ﹤0.01% |
24,420
-25,260
| -51% | -$429K |
|
|
CIM
7378
PUT
Chimera Investment
CIM
$980M
| $356K | ﹤0.01% |
9,333
-667
| -7% | -$22.8K |
|
7379
PUT
Honda
HMC
$41.2B
| $356K | ﹤0.01% |
+11,800
| New | +$340K |
|
|
TLC
7380
DELISTED
Taiwan Liposome Company, Ltd. American Depository Shares
TLC
| $356K | ﹤0.01% |
58,789
+41,216
| +235% | +$217K |
|
7381
PUT
Terex
TEX
$7.58B
| $355K | ﹤0.01% |
7,700
-1,200
| -13% | -$49.2K |
|
|
SYRS
7382
PUT
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $355K | ﹤0.01% |
+4,750
| New | +$493K |
|
7383
CALL
EnerSys
ENS
$6.79B
| $354K | ﹤0.01% |
+3,900
| New | +$357K |
|
7384
State Street Fixed Income Sector Rotation ETF
FISR
$494M
| $354K | ﹤0.01% |
11,518
-28,164
| -71% | -$882K |
|
7385
IQ Candriam International Equity ETF
IQSI
$275M
| $354K | ﹤0.01% |
12,417
-58,319
| -82% | -$1.64M |
|
7386
Kemper
KMPR
$1.55B
| $354K | ﹤0.01% |
4,438
+546
| +14% | +$42.1K |
|
7387
NETSCOUT
NTCT
$2.81B
| $354K | ﹤0.01% |
12,564
+4,857
| +63% | +$142K |
|
7388
LCI Industries
LCII
$2.55B
| $353K | ﹤0.01% |
+2,671
| New | +$373K |
|
7389
CALL
Mercury Systems
MRCY
$6.52B
| $353K | ﹤0.01% |
5,000
-1,900
| -28% | -$137K |
|
|
VENAU
7390
DELISTED
Venus Acquisition Corporation Units
VENAU
| $353K | ﹤0.01% |
+35,143
| New | +$359K |
|
7391
Amneal Pharmaceuticals
AMRX
$5.71B
| $352K | ﹤0.01% |
52,369
+23,084
| +79% | +$128K |
|
7392
PUT
FormFactor
FORM
$8.79B
| $352K | ﹤0.01% |
7,800
-100
| -1% | -$4.55K |
|
7393
Veritone
VERI
$134M
| $352K | ﹤0.01% |
14,653
-27,575
| -65% | -$983K |
|
|
DMDV
7394
DELISTED
AAM S&P Developed Markets High Dividend Value ETF
DMDV
| $352K | ﹤0.01% |
14,588
+414
| +3% | +$9.75K |
|
|
ATCO
7395
DELISTED
Atlas Corp.
ATCO
| $352K | ﹤0.01% |
+25,774
| New | +$330K |
|
7396
Arrow Dow Jones Global Yield ETF
GYLD
$38.1M
| $351K | ﹤0.01% |
24,603
-72,696
| -75% | -$1.01M |
|
7397
Ingredion
INGR
$6.53B
| $351K | ﹤0.01% |
3,904
-15,804
| -80% | -$1.35M |
|
7398
InnovAge Holding
INNV
$1.48B
| $351K | ﹤0.01% |
+13,623
| New | +$336K |
|
7399
Nektar Therapeutics
NKTR
$2.53B
| $351K | ﹤0.01% |
1,170
-2,585
| -69% | -$805K |
|
7400
PUT
Trupanion
TRUP
$1.27B
| $351K | ﹤0.01% |
4,600
-13,600
| -75% | -$1.39M |
|
Similar funds
Jane Street's Q1 2021 Portfolio in Review
As of Q1 2021, Jane Street held 10,046 positions worth $201B, up 1.1% from $199B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jane Street's Q1 2021 filing shows 2,632 new, 3,317 increased, 3,042 reduced and 1,017 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,305,886 shares worth $430M. The largest sale was Tesla, an estimated $1.54B.
By sector, the portfolio is most concentrated in Consumer Discretionary at 2.8% of assets, down from 3.3% a quarter earlier, followed by Communication Services and Technology.
- Jane Street's largest Q1 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,305,886 shares worth $430M.
- Jane Street added most to Baidu in Q1 2021, an estimated $1.35B increase.
- Jane Street's biggest Q1 2021 reduction was Tesla, cutting an estimated $1.54B.
- Jane Street fully exited iShares MSCI Emerging Markets ETF in Q1 2021, selling an estimated $586M.
- Jane Street's ten largest holdings make up 32% of its $201B portfolio in Q1 2021.
- Jane Street opened 2,632 new positions and closed 1,017 in Q1 2021.
- Jane Street's portfolio value rose 1.1% quarter-over-quarter to $201B.
Based on Jane Street's 13F filing for Q1 2021, filed 18 May 2021.